Table 6.
Main outcome at 7-day follow up from tocilizumab administration.
| Main outcomes – no. % | Patients |
|---|---|
| Discharge | 34 (41.5%) |
| In-patient in conventional ward | 9 (11.0%) |
| Intensive care unit | 14 (17.1%) |
| Death | 22 (26.8%) |
| Transferred | 3 (3.7%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.